Antipsychotics with inverse agonist activity at the dopamine D3 receptor
- 1 October 1996
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neural Transmission
- Vol. 103 (10), 1163-1175
- https://doi.org/10.1007/bf01271201
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Novel dopamine receptors half a decade laterTrends in Pharmacological Sciences, 1995
- The two-state model of receptor activationTrends in Pharmacological Sciences, 1995
- Inverse agonism: pharmacological curiosity or potential therapeutic strategy?Trends in Pharmacological Sciences, 1995
- Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell lineEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Rhodopsin mutation G90D and a molecular mechanism for congenital night blindnessNature, 1994
- Characterization of the human dopamine D3 receptor expressed in transfected cell linesEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor functionCell, 1993
- Stable expression of human D3 dopamine receptors in GH4C1 pituitary cellsFEBS Letters, 1992
- Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990